Keyword: Biopharma

News

Germany’s Merck Expands Venture Capital Fund

16.06.2016 - German chemical and pharmaceutical producer Merck has increased its venture capital funding under its renamed Merck Ventures umbrella. At the same time, the total investment...

News

Novozymes Separates Biopharma Activities

20.01.2016 - Danish biotechnology company Novozymes has separated its biopharma activities into an independent company called Albumedix. The new company will be headquartered in Lyngby, Denmark...

Strategy & Management

Bio On Demand

07.10.2015 - The ability to rapidly deploy manufacturing capacity will be a strategic asset of the pharmaceutical industry in the future. NNE Pharmaplan has developed the “Bio on demand”...

Plant Construction & Process Technology

Growth Amid Risk

07.10.2015 - Interest in the biopharma industry continues to grow, making the development and manufacturing services of the biologic entities for both drug substance and drug product a more...

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...

Markets & Companies

Leaving the Patent Cliff Behind

07.10.2015 - The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...

Strategy & Management

Significant Value Creation

03.09.2015 - In September 2014, Merck announced the €13.1 billion acquisition of Sigma-Aldrich, which by mid-August has received antitrust clearance from all relevant jurisdictions including...

Plant Construction & Process Technology

United in Philosophy and Approach

11.09.2013 - Smooth Connection — Custom manufacturing isn't as easy as filling an order and calling it a day. The gears that interlink a CMO and its customer have to be well oiled and a perfect...